177 related articles for article (PubMed ID: 19531804)
1. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling.
Mizwicki MT; Norman AW
Sci Signal; 2009 Jun; 2(75):re4. PubMed ID: 19531804
[TBL] [Abstract][Full Text] [Related]
2. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):69-82. PubMed ID: 16055325
[TBL] [Abstract][Full Text] [Related]
3. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):243-62. PubMed ID: 17368177
[TBL] [Abstract][Full Text] [Related]
4. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
Mizwicki MT; Bishop JE; Norman AW
Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
[TBL] [Abstract][Full Text] [Related]
5. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
[TBL] [Abstract][Full Text] [Related]
6. Minireview: vitamin D receptor: new assignments for an already busy receptor.
Norman AW
Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
8. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Carlberg C; Molnár F
Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro.
Huhtakangas JA; Olivera CJ; Bishop JE; Zanello LP; Norman AW
Mol Endocrinol; 2004 Nov; 18(11):2660-71. PubMed ID: 15272054
[TBL] [Abstract][Full Text] [Related]
11. 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells.
Capiati D; Benassati S; Boland RL
J Cell Biochem; 2002; 86(1):128-35. PubMed ID: 12112023
[TBL] [Abstract][Full Text] [Related]
12. A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications.
Mizwicki MT; Menegaz D; Yaghmaei S; Henry HL; Norman AW
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):98-105. PubMed ID: 20398762
[TBL] [Abstract][Full Text] [Related]
13. The role of receptor topology in the vitamin D3 uptake and Ca(2+) response systems.
Morrill GA; Kostellow AB; Gupta RK
Biochem Biophys Res Commun; 2016 Sep; 477(4):834-840. PubMed ID: 27369077
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol potentiates vitamin D and nuclear receptor signaling.
Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
[TBL] [Abstract][Full Text] [Related]
15. Nongenomic and genomic effects of 1α,25(OH)2 vitamin D3 in rat testis.
Zanatta L; Zamoner A; Zanatta AP; Bouraïma-Lelong H; Delalande C; Bois C; Carreau S; Silva FR
Life Sci; 2011 Oct; 89(15-16):515-23. PubMed ID: 21565203
[TBL] [Abstract][Full Text] [Related]
16. Different shapes of the steroid hormone 1alpha,25(OH)(2)-vitamin D(3) act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses.
Norman AW; Henry HL; Bishop JE; Song XD; Bula C; Okamura WH
Steroids; 2001; 66(3-5):147-58. PubMed ID: 11179722
[TBL] [Abstract][Full Text] [Related]
17. What do we learn from the genome-wide perspective on vitamin D3?
Carlberg C
Anticancer Res; 2015 Feb; 35(2):1143-51. PubMed ID: 25667505
[TBL] [Abstract][Full Text] [Related]
18. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
19. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein.
Norman AW; Ishizuka S; Okamura WH
J Steroid Biochem Mol Biol; 2001; 76(1-5):49-59. PubMed ID: 11384863
[TBL] [Abstract][Full Text] [Related]
20. The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling.
Quack M; Carlberg C
Mol Pharmacol; 2000 Feb; 57(2):375-84. PubMed ID: 10648648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
